Aligos Therapeutics, Inc. (ALGS)
USD 33.01
(-4.24%)
USD 33.01
(-4.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 15.52 Million | 13.9 Million | 4.35 Million | - | - | - |
| Cost of Revenue | 3.06 Million | 3.67 Million | 104.15 Million | 3.32 Million | 2.29 Million | 1.29 Million |
| Gross Profit | 12.46 Million | 10.23 Million | -99.79 Million | -3.32 Million | -2.29 Million | -1.29 Million |
| Operating Expenses | 103.65 Million | 111.48 Million | 132.68 Million | 97.83 Million | 54.04 Million | 13.66 Million |
| Selling, General and Administrative Expenses | 30.61 Million | 26.41 Million | 28.52 Million | 17.94 Million | 10 Million | 3.2 Million |
| Research and Development Expenses | 73.04 Million | 85.07 Million | 104.15 Million | 79.89 Million | 44.03 Million | 10.45 Million |
| Other Expenses | - | - | - | -10.54 Million | 302 Thousand | -435 Thousand |
| Cost and Expenses | 103.65 Million | 111.48 Million | 132.68 Million | 97.83 Million | 54.04 Million | 13.66 Million |
| Operating Income | -87.42 Million | -97.58 Million | -128.32 Million | -97.83 Million | -54.04 Million | -13.66 Million |
| Interest Expense | - | 1.64 Million | 132 Thousand | 10.54 Million | - | - |
| Income Tax Expense | 795 Thousand | 106 Thousand | 143 Thousand | 161 Thousand | 85 Thousand | -272 Thousand |
| Earnings before Tax | -86.88 Million | -95.94 Million | -128.18 Million | -108.38 Million | -52.17 Million | -13.93 Million |
| Net Income | -87.67 Million | -96.04 Million | -128.33 Million | -108.54 Million | -52.26 Million | -13.93 Million |
| Earnings Per Share Basic | -3.52 | -2.25 | -3.22 | -3.18 | -2.38 | -0.66 |
| Earnings Per Share Diluted | -3.52 | -2.25 | -3.22 | -3.18 | -2.38 | -0.66 |
| Weighted Average Shares Outstanding | 24.87 Million | 42.69 Million | 39.85 Million | 34.17 Million | 21.93 Million | 21.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.87 Million | 42.69 Million | 39.85 Million | 34.17 Million | 21.93 Million | 21.17 Million |
| Gross Margin | 0.80 | 0.74 | -22.89 | - | - | - |
| EBIT Margin | -5.40 | -7.02 | -29.44 | - | - | - |
| Profit Margin | -5.65 | -6.91 | -29.44 | - | - | - |
| EBITDA | -83.81 Million | -93.9 Million | -124.54 Million | -105.05 Million | -49.88 Million | -12.37 Million |
| Earnings Before Tax Margin | -5.63 | -7.02 | -29.44 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.06 Million | 986 Thousand | 15.52 Million | 2.68 Million | 3.23 Million | 6.88 Million |
| Cost of Revenue | 610 Thousand | 674 Thousand | 3.06 Million | 775 Thousand | 681 Thousand | 769 Thousand |
| Gross Profit | 451 Thousand | 312 Thousand | 12.46 Million | 1.9 Million | 2.55 Million | 6.11 Million |
| Operating Expenses | 26.86 Million | 23.03 Million | 99.88 Million | 27.9 Million | 22.31 Million | 26.02 Million |
| Selling, General and Administrative Expenses | 5.76 Million | 6.66 Million | - | 5.64 Million | 6.44 Million | 9.24 Million |
| Research and Development Expenses | 21.09 Million | 16.36 Million | - | 22.25 Million | 15.86 Million | 16.78 Million |
| Other Expenses | 31.34 Million | -13.37 Million | - | -460 Thousand | 54 Thousand | 152 Thousand |
| Cost and Expenses | 27.47 Million | 23.03 Million | 102.95 Million | 28.67 Million | 22.31 Million | 26.02 Million |
| Operating Income | -26.41 Million | -22.04 Million | -87.42 Million | -25.99 Million | -19.07 Million | -19.14 Million |
| Interest Expense | - | -12.79 Million | - | -1 Million | - | - |
| Income Tax Expense | 189 Thousand | -24 Thousand | 795 Thousand | -30 Thousand | 29 Thousand | 757 Thousand |
| Earnings before Tax | 5.25 Million | -34.83 Million | -86.88 Million | -27.92 Million | -18.01 Million | -18.03 Million |
| Net Income | 5.06 Million | -34.86 Million | -87.67 Million | -27.89 Million | -18.04 Million | -18.79 Million |
| Earnings Per Share Basic | 0.81 | -5.58 | - | -0.37 | -0.41 | -0.43 |
| Earnings Per Share Diluted | 0.81 | -5.58 | - | -0.37 | -0.41 | -0.43 |
| Weighted Average Shares Outstanding | 6.25 Million | 6.25 Million | 64.26 Million | 75.1 Million | 43.49 Million | 43.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.26 Million | 6.25 Million | 64.26 Million | 75.1 Million | 43.49 Million | 43.21 Million |
| Gross Margin | 0.43 | 0.32 | 0.80 | 0.71 | 0.79 | 0.89 |
| EBIT Margin | -24.32 | -22.36 | - | -9.41 | -5.68 | -2.67 |
| Profit Margin | 4.77 | -35.36 | -5.65 | -10.40 | -5.57 | -2.73 |
| EBITDA | -25.8 Million | -22.04 Million | - | -25.22 Million | -18.39 Million | -18.37 Million |
| Earnings Before Tax Margin | -24.90 | -22.36 | -5.63 | -9.70 | -5.89 | -2.78 |
FORM
UEL
IDX
PARAA
DSX-PB
4095